Please select whether you prefer to view the MDPI pages with a view tailored for mobile displays or to view the MDPI
pages in the normal scrollable desktop version. This selection will be stored into your cookies and used automatically
in next visits. You can also change the view style at any point from the main header when using the pages with your
New Journal Biomedicines (ISSN 2227-9059) Launched
MDPI is pleased to announce the launch of Biomedicines (ISSN 2227-9059), a new journal aimed at bridging the gap between biological research and clinical practice, led by the Editor-in-Chief Prof. Dr. Kenneth Cornetta. Biomedicines provides a forum for all aspects related to biomedicines—medicines that are made from, or contain, biological active substances. Biomedicines welcomes theoretical and research papers in the field of biologic agents. These include vaccines, monoclonal antibodies, immunotherapy, cell therapeutics, and gene therapy.
The Founding Editor-in-Chief Prof. Dr. Kenneth Cornetta from The Department of Medical and Molecular Genetics, Indiana University School of Medicine mainly works on gene therapy work. His research focus is on using viral based gene transfer as a means of introducing genetic sequences that will correct mutations and ameliorate disease. To date Dr. Cornetta’s lab has certified over 30 products for Phase I/II trials and has published extensively on release testing to meet FDA requirements.
We hope that Biomedicines will become an invaluable resource to those working in basic scientific studies, product development, product manufacture, clinical trials and the wider scientific community.